Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-20

Clinical Trial Update: Efficacy of Chatbot for Irritable Bowel Syndrome (IBS) Patients [NA]

View source ↗

Summary

A clinical trial update shows ongoing enrollment for a study assessing the efficacy of a chatbot intervention in patients with various forms of irritable bowel …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department | Conditions: Irritable Bowel Syndrome, Irritable Bowel Syndrome - Constipation | NA | Status: ENROLLING_BY_INVITATION